| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | | Total Revenue | 83,523 | 108,363 | | Cost of Revenue | 35,687 | 23,323 | | | Gross Profit | 47,836 | 85,040 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 23,133 | 11,291 | | Non Recurring | 42,121 | 7,400 | | Others | (24) | 78 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (17,394) | 66,271 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,926 | 6,840 | | Earnings Before Interest And Taxes | (13,468) | 79,685 | | Interest Expense |
-
|
-
| | Income Before Tax | (13,468) | 79,685 | | Income Tax Expense | (1,623) | 550 | | Minority Interest | (1,531) | (18,002) | | | | Net Income From Continuing Ops | (15,322) | 54,559 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (15,322) | 54,559 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($15,322) | $54,559 |
|
1.01% Nasdaq 
Income Statement
